Warner Records announced has teamed up with Sickamore's Three Times Louder imprint and named singer Laila the partnership's ...

Rynia Kando, 26, won the Golden Banana for her performance at the “Minions & Monsters” premiere. She unpacks the now viral ...

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...

Billy Ray Cyrus is sharing his near-death experience. The singer recently revealed that he nearly lost his life while battling a severe infection. The harrowing experience eventually helped him find ...

Obesity patients at Juan Manuel Esparza Luna’s clinic in Chihuahua, Mexico, have options to slim down, with access to Novo Nordisk A/S and Eli Lilly & Co.’s blockbuster shots. But many leave his ...

We may earn commission from links on this page, but we only recommend products we love. Promise. I consider shopping at TJ Maxx and Marshalls a professional sport. Weaving through infinite shopping ...

Raiders defensive end Maxx Crosby says he has long since moved on from the failed attempt to trade him to the Ravens. “I don’t really want to talk about that, to be honest. It’s water under the bridge ...

Eli Lilly's Jacob Van Naarden says Lilly is using the financial strength from its GLP-1 drugs like Mounjaro and Zepbound to fund its new dealmaking strategy. Van Naarden recently became Lilly's head ...

First, let's take a look at Lilly's path to GLP-1 dominance and consider why the stock has taken off recently. Novo Nordisk entered this market first, back in 2017, with Ozempic, which regulators ...

Hi, everyone. Thank you so much for being with us today. It is my pleasure to be sharing the stage with Dan Skovronsky, Chief Scientific Officer as well as Chief Product Officer at Eli Lilly. We will ...

Eli Lilly has splashed up to $3.8 billion on an infectious disease pipeline, acquiring Curevo, LimmaTech Biologics and Vaccine Company to extend its buying spree into viral and bacterial pathogen R&D.